aTyr Pharma, Inc. (ATYR) Tops Q4 EPS by 5c
Get Alerts ATYR Hot Sheet
Join SI Premium – FREE
aTyr Pharma, Inc. (NASDAQ: ATYR) reported Q4 EPS of ($0.18), $0.05 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on aTyr Pharma, Inc. (ATYR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Misses Q2 EPS by 16c; offers guidance
- Isabella Bank Corporation (ISBA) Misses Q2 EPS by 23c
- First Resource Bank (FRSB) Tops Q2 EPS by 92c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share